1
Kishi Masahiro: Method of desalinating saline water and apparatus therefor. Mechano Chemical Research Institute, Kishi Masahiro, TSUKUNI Hajime, September 26, 1996: WO/1996/029142 (4 worldwide citation)

A method of desalinating brine or seawater by using a hollow-fiber reverse osmosis membrane, and an apparatus for practicing the method aiming at providing a novel, simple and economical method capable of prolonging the lifetime of a reverse osmosis membrane, and an apparatus for practicing this met ...


2
Arbogast Robert E, Kania Bruce G, Capper James W, Colvin James M: Gel et dispositifs de matelassage, Gel and cushioning devices. Arbogast Robert E, Kania Bruce G, Capper James W, Colvin James M, Ohio Willow Wood Company, OGILVY RENAULT SENCRLSRL, September 26, 1996: CA2190764 (3 worldwide citation)

The invention relates to a polymeric gel and various articles of manufacture suc h as a cushion liner, a cushion locking liner, an open-ended cushion knee or elbow sleeve, and a cushion flat sheet, all useful fo r increasing the comfort of the wearer. Also described are sleeve members and liners for ...


3
Hideji Tajima: Procede et dispositif pour le traitement de liquides a laide dun distributeur, Liquid processing method making use of pipette device and apparatus for same. Precision System Science, FREEDMAN GORDON, September 26, 1996: CA2183638 (3 worldwide citation)

Technological preposition of the present invention is a liquid processing method making use of a pipette device which sucks a liquid containing a target high molecular weight substance from inside of a vessel through a tip detachably set on a sucking port or a discharging port of a liquid sucking/di ...


4
Rausch Carl W, Gawryl Maria S, Houtchens Robert A, Laccetti Anthony J, Light William R, Jacobs Edward E Jr: Stable polymerized hemoglobin blood-substitute. Biopure Corporation, PIERCE N Scott, September 26, 1996: WO/1996/029346 (2 worldwide citation)

A method for producing a stable polymerized hemoglobin blood-substitute from blood characterized in the use of a chromatographic column, is disclosed. The method of this invention includes mixing blood with an anticoagulant to form a blood solution, washing the red blood cells in the blood solution ...


5
Kwon Byoung S, Kang Chang Yuil: Monoclonal antibody against human receptor protein 4-1bb and methods of its use for treatment of diseases. Indiana University Foundation, MICHAELS Christopher A, September 26, 1996: WO/1996/029348 (2 worldwide citation)

Disclosed herein is a monoclonal antibody against H4-1BB that can be used to enhance or suppress T-cell activation and proliferation by treating T-cells that have expressed receptor protein H4-1BB with the anti H4-1BB monoclonal antibody. Also disclosed herein is cDNA for the human receptor H4-1BB. ...


6
Giertych Joseph A: Method of manufacturing and storing solutions. Baxter International, BORECKI Thomas S, September 26, 1996: WO/1996/029103 (2 worldwide citation)

The present invention provides improved methods for manufacturing solutions including medical solutions. To this end, in an embodiment, a method for preparing a medical solution is provided comprising the steps of: placing a solution in a gas permeable container; and allowing carbon dioxide to perme ...


7
Holzberger Ian Raymond, Turner Duncan William, Hourn Michael Matthew: Procede de lessivage de minerais sous une pression atmospherique, Atmospheric mineral leaching process. Highlands Gold Properties, Mim Holdings, Highlands Frieda, Mim Holdings, GOUDREAU GAGE DUBUC, September 26, 1996: CA2215963 (1 worldwide citation)

The present invention relates to a method of processing a sulphide mineral compo sition which at least partly comprises an iron containing mineral, the method comprising the steps of: (a) milling said composi tion to a particle size P80 of 20 microns or less; (b) leaching said composition with a sol ...


8
Mandel Gail, Chong Jayhong Andrew: Rest protein and dna. Research Foundation Of State University Of New York, BLOOM Allen, September 26, 1996: WO/1996/029433 (1 worldwide citation)

The invention provides a substantially pure nucleic acid encoding a protein that inhibits the expression of neural proteins in non-neural tissues. The invention also provides a substantially pure nucleic acid encoding a protein that binds to a promoter sequence having at least about 90 % homology to ...


9
Zhang Zhaoda, Tang Jimmy X, Tang Jin Yan: Thiono triester modified antisense oligodeoxynucleotide phosphorothioates. Hybridon, Zhang Zhaoda, Tang Jimmy X, Tang Jin Yan, GREENFIELD Michael S, September 26, 1996: WO/1996/029337 (1 worldwide citation)

Antisense oligonucleotides having improved cellular uptake, increased nuclease resistance, and thermodynamically more stable target-binding capacity are disclosed. These novel oligonucleotides are characterized by having from 1 to 10 thiono-triester phosphorothioate internucleoside linkages bearing ...


10
Tsutsumi Kazuhiro, Inaba Takashi, Tanaka Toshizo: Diphenylmethyl-azetidinone compounds and elastase inhibitor. Japan Tobacco, Tsutsumi Kazuhiro, Inaba Takashi, Tanaka Toshizo, TAKASHIMA Hajime, September 26, 1996: WO/1996/029307 (1 worldwide citation)

Diphenylmethyl-azetidinone compounds represented by general formula (I) or pharmacologically acceptable salts thereof, and medicinal compositions, elastase inhibitor and antiinflammatory agent containing the same; wherein R?1¿ and R?2¿ represent alkyl or alkylene; A represents substituted amino; B?1 ...